Client News
Filter by:
- Jan 5 2023 Galectin Therapeutics Announces the End of Enrollment of NAVIGATE, its Seamless, Adaptive Phase 2b/3 Study of Belapectin in Patients with Liver Cirrhosis Caused by Non-Alcoholic Steatohepatitis
- Jan 5 2023 Genprex Signs Exclusive License to Additional Diabetes Technology with the University of Pittsburgh
- Jan 4 2023 Processa Pharmaceuticals To Present an Update on Its Future Therapeutic Focus and Strategy at the Biotech Showcase on January 11, 2023.
- Jan 4 2023 Oramed Granted U.S. Combination Therapy Patent for Oral GLP-1 & Insulin for the Treatment of Diabetes
- Jan 4 2023 Genprex Announces Selection of Preclinical Data for Oral Presentation at 16th International Conference on Advanced Technologies & Treatments for Diabetes
- Dec 28 2022 Luokung Launches "Carbon Peaking and Carbon Neutrality" Data Service with More than US$70 Million in Forecasted Revenue
- Dec 27 2022 Pingtan Marine Enterprise Announces Receipt of Nasdaq Notification Letter
- Dec 27 2022 Luokung Announces Financial Results for First Half 2022, Reports Record Revenues of Approximately $62.8 Million for the Period
- Dec 22 2022 Pingtan Marine Enterprise Announces Results of Annual General Meeting
- Dec 21 2022 Oramed Letter to Shareholders